Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit, M Blatzer… - International journal of …, 2021 - Elsevier
Introduction Urgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit, M Blatzer… - International Journal …, 2021 - anr.hal.science
IntroductionUrgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit, M Blatzer… - International Journal of …, 2021 - hal.univ-smb.fr
IntroductionUrgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

[HTML][HTML] Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, A Petit, M Blatzer, F Vinckier… - 2020 - europepmc.org
Urgent action is needed to fight the ongoing COVID-19 pandemic by reducing the number of
infected people along with the infection contagiousness and severity. Chlorpromazine …

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit… - International Journal …, 2021 - cnrs.hal.science
IntroductionUrgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit… - International Journal …, 2021 - u-paris.hal.science
IntroductionUrgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

Inhibition of the replication of SARS-CoV-2 in human cells by the fda-approved drug chlorpromazine.

M Plaze, D Attali, M Prot, AC Petit, M Blatzer, F Vinckier… - 2021 - cabidigitallibrary.org
Introduction: Urgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

[PDF][PDF] Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit, M Blatzer, F Vinckier… - researchgate.net
Abstract (249 words) Introduction: Urgent action is needed to fight the ongoing COVID-19
pandemic by reducing the number of infected people along with the infection …

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit, M Blatzer… - International Journal of …, 2021 - hal.uvsq.fr
IntroductionUrgent action is needed to fight the ongoing coronavirus disease 2019 (COVID-
19) pandemic by reducing the number of infected cases, contagiousness and severity …

[PDF][PDF] Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

M Plaze, D Attali, M Prot, AC Petit, M Blatzer, F Vinckier… - covid19.sld.cu
Urgent action is needed to fight the ongoing COVID-19 pandemic by reducing the number of
infected people along with the infection contagiousness and severity. Chlorpromazine …